Discovery and Development of Novel Antibacterial Agents
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Novel Antimicrobial Agents".
Deadline for manuscript submissions: closed (1 September 2022) | Viewed by 15465
Special Issue Editor
Interests: antibiotic discovery; host-bacteria interaction
Special Issue Information
Dear Colleagues,
The particularly noteworthy emergence and dissemination of multidrug-resistant bacterial pathogens are one of the biggest ever crises to One Health worldwide. Meanwhile, the depletion of developing pipelines of antibacterial drugs further aggravates the threat created by pathogenic bacteria, leading to almost no new antibiotics introduced to the clinic in the past decade. To accelerate the process of antibiotic discovery, novel antibacterial agents and alternative strategies including new antibiotics, antibiotic adjuvants, antivirulence approaches, probiotics, immune-modulators, and phages are urgently required to address such a global threat.
This Special Issue will focus on the following topics: (1) the discovery of novel antibacterial natural products derived from microbial organisms, plants, etc.; (2) the identification and conformation of potential antibacterial targets particularly in Gram-negative bacteria; (3) a deep mechanistic understanding of the diverse ways for revitalizing existing antibiotics, to shed light on developing rational medication; (4) the emerging approach of host-directed therapy attracts increasing attentions recently by modulating either host immune responses or colonization resistance, to eliminate or diminish infections associated with multidrug-resistant bacterial pathogens.
Prof. Dr. Kui Zhu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic
- antibiotic adjuvant
- natural product
- probiotic
- target